Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Number of employees : 8 125 persons.
Sales per Businesses
20152016Delta
JPY (in Million)%JPY (in Million)%
Pharmaceutical Business415,124100%431,701100% +3.99%
Sales per Regions
20152016Delta
JPY (in Million)%JPY (in Million)%
Japan337,18081.2%314,76472.9% -6.65%
Europe48,61811.7%66,96215.5% +37.73%
Asia17,2454.2%18,5074.3% +7.32%
North America11,6962.8%31,0437.2% +165.42%
Other385.000.1%425.000.1% +10.39%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD622007Executive President & Representative Director
Michihiro Tsuchiya, PhD691976Chairman
Eizou Tabaru582014Director, IR Contact, Manager-Finance & Accounting
Yoshiaki Ishizaki612007Director, Managing Executive Officer & GM-Sales
Seiichi Murakami591980Director & Head-External Affairs
Takashi Kobayashi611980Director, Managing Executive Officer & Head-Tokyo
Shigehiko Hattori752011Independent Director
Tsutomu Anno--Executive Officer & Deputy General Manager-Sales
Tetsuo Yoshikawa--Executive Officer & Manager-Kyushu Branch Sales
Shigeki Nakata--Executive Officer & Deputy General Manager-Sales
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 0.001 561,417,916 229,713,075 40.9% 429,225 0.1% 40.9%
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 12,065,000 2.15%
Mitsubishi UFJ Financial Group, Inc. 9,372,113 1.67%
BlackRock Fund Advisors 6,217,200 1.11%
The Vanguard Group, Inc. 4,645,411 0.83%
Nipro Corp. 3,821,000 0.68%
Mitsubishi Tanabe Pharma Employee Stock Ownership Plan 3,685,000 0.66%
Norges Bank Investment Management 3,615,547 0.64%
State Street Global Advisors Ltd. 3,251,754 0.58%
Tokio Marine Holdings, Inc. 3,132,900 0.56%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1911.50%49,723,034 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%47,064,327 USD
Medipal Holdings Corp (7459) 2,125,7320.87%36,310,500 USD
VITAL KSK HOLDINGS INC (3151) 1,455,2962.38%15,385,957 USD
ROHTO PHARMACEUTICAL CO., LTD. (4527) 650,0000.55%11,406,005 USD
Mitsubishi Tanabe Pharma Corp (4508) 429,2000.076%8,356,503 USD
T&D Holdings Inc (8795) 572,5000.084%6,924,370 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%4,613,408 USD
KOEI CHEMICAL COMPANY, LIMITED (4367) 910,0003.71%2,208,215 USD
Create SD Holdings Co Ltd (3148) 3,6000.0054%75,368 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MITSUBISHI TANABE PHAR..4.63%10 650
JOHNSON & JOHNSON9.09%304 863
PFIZER INC.-2.23%191 517
ROCHE HOLDING LTD.-19.65%190 397
NOVARTIS AG-20.79%180 387
MERCK & CO., INC.14.12%166 200
SANOFI-4.20%104 405
BRISTOL-MYERS SQUIBB C..-18.55%93 639
GLAXOSMITHKLINE PLC6.34%90 098
BAYER AG-24.74%78 134
ELI LILLY AND CO-19.53%74 848
ALLERGAN PLC-38.90%71 618
NOVO NORDISK A/S-40.59%69 546
ASTRAZENECA PLC-12.54%64 740
ABBOTT LABORATORIES-14.45%56 566
SHIRE PLC-2.92%52 262
TAKEDA PHARMACEUTICAL ..-22.58%32 110
ASTELLAS PHARMA INC-10.48%28 972
MYLAN NV-33.68%19 189
EISAI CO., LTD-18.61%16 704
SHIONOGI & CO LTD-2.10%16 335
Sector Pharmaceuticals - NEC
Mitsubishi Tanabe Pharma C : Connections
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
© 2016 People , Fundamentals and Ownership